Area of research
Neurology · Epidemiology
Research interest
Research interests include Myasthenia Gravis and Thymoma, Acute Ischemic Stroke Management, Peripheral Neuropathies and Disorders, and Neuroinflammation and Neurodegeneration Mechanisms.
New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis
<scp>ADAPT NXT</scp>: Fixed Cycles or Every‐Other‐Week <scp>IV</scp> Efgartigimod in Generalized Myasthenia Gravis
Single-Cell Transcriptomics Identifies a Prominent Role for the MIF-CD74 Axis in Myasthenia Gravis Thymus
The burden of disease in seronegative myasthenia gravis: a patient-centered perspective
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data
Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy–A pilot study
The crux of NPO paradox revealed by increased pneumonia incidence in post-stroke dysphagia patients with dietary restrictions
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
The economic burden of Myasthenia gravis from the patient´s perspective and reflected in German claims data
Recanalization and reperfusion in clinically-relevant porcine model of stroke
<i>Ide</i> Copy Number Variant Does Not Influence Stroke Severity in 2 C57BL/6J Mouse Models nor in Humans: An Exploratory Study
Recruiting patients into a healthcare services trial: lessons learned from a feasibility study to investigate a patient-oriented navigation intervention for age-associated diseases
Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
Assessing post-stroke cognition in pre-clinical models: Lessons and recommendations from a multi-center study
Functional Signature of LRP4 Antibodies in Myasthenia Gravis
Ravulizumab and Efgartigimod in Myasthenia Gravis
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort
Fatigue and associated factors in myasthenia gravis: a nationwide registry study
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction
Time to response with ravulizumab, a long‐acting terminal complement inhibitor, in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis
Robotic-assisted extended thymectomy for large resectable thymoma: 21 years’ experience
Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany
App- and Wearable-Based Remote Monitoring for Patients With Myasthenia Gravis and Its Specialists: Feasibility and Usability Study
Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies
The telemedical platform MyaLink for remote monitoring in myasthenia gravis – rationale and protocol for a proof of concept study
Myasthenia Gravis: utilising cross-platform quantitative content analysis to uncover and validate unmet needs
POLAR: prediction of prolonged mechanical ventilation in patients with myasthenic crisis
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG